Cat.#: ASSD-139
| Description | Adenosine A1AR Affinity-Based Probe (AfBP) incubate with live cells or membrane fractions can selectively label the desired receptor in the presence of other proteins. AfBP acts as a partial agonist which is highly specific to the A1AR and binds covalently. Apparent pKi values at A1AR are 7.8 and 9.5 (following a 4h preincubation), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Applications | For use in confocal microscopy, SDS-PAGE and chemical proteomics profiling applications. |
| Chemical Name | 4-((3-((6-Amino-4-(benzo[d][1,3]dioxol-5-yl)-3,5-dicyanopyridin-2-yl)thio)propyl)(prop-2-yn-1-yl)carbamoyl)benzenesulfonyl fluoride |
| Molecule Weight | 577.6 |
| Molecular formula | C27H20FN5O5S2 |
| PubChem identifier | 167312224 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-211 | 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) | 100 mg, 1 g | inquiry |
| ASSD-189 | 7-Hydroxycoumarin-3-carboxylic acid (AC189) | 100 mg | inquiry |
| ASSD-129 | Fluorescent 5-HT1A antagonist [NAN-190] (AC129) | 50 μg | inquiry |
| ASSD-220 | Nitrofluorescein, Isomer 2 (AC220) | 1 g | inquiry |
| ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
| ASSD-148 | Sulforhodamine 101 (AC148) | 50 mg, 100 mg | inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
| ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
| ASSD-123 | Fluorescent β2 antagonist [(S)-propranolol-red] (AC123) | 500 μg | inquiry |
| ASSD-167 | Fura-2 AM (Cell permeant) (AC167) | 1 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.